NEW YORK (
CHANGE IN RATINGS
is downgraded to hold at TheStreet Ratings.
was initiated with a neutral rating at Credit Suisse. Valuation call, based on a $28 price target.
was initiated with a neutral rating at JPMorgan. $54 price target. Stock is also pricing in solid expected growth.
was initiated with a neutral rating at Goldman Sachs. $24 price target. Company is performing well in a difficult environment.
was initiated with a buy rating at Keybanc. $22 price target. Company has an attractive portfolio, but trades at a discount to its peers.
was upgraded to outperform from perform at Oppenheimer. $125 price target. Positioning for 2012.
(GS - Get Report)
was initiated with an equal-weight rating at Evercore. $100 price target. Growth/return profiles unlikely to return anytime soon.
(KLAC - Get Report)
was upgraded to overweight at JPMorgan. Industry fundamentals appear to be at a bottom.
was initiated with an equal-weight rating at Evercore. $17 price target. Many uncertainties from regulatory and macro perspective.
was downgraded to neutral at JPMorgan.
was upgraded to buy from hold at Jefferies. $59.50 price target. Recent EPA decision regarding region haze will boost earnings of regulated utility.
was initiated with an outperform rating at Credit Suisse. $49 price target. Stock is attractive, following a 65% decline.
(T - Get Report)
was downgraded at JPMorgan to neutral from overweight. New analyst also has a $31 price target.
was initiated with an equal-weight rating at Evercore. $48 price target. Solid FCF generator with modest growth.
STOCK COMMENTS / EPS CHANGES
(AA - Get Report)
price target lowered to $9.50 at UBS. Lowering estimates to reflect lower realized pricing, FX, and macro outlook. Neutral rating.
estimates, target raised at Credit Suisse. Shares of AGCO now seen reaching $47, according to Credit Suisse. Estimates also increased, as the GSI purchase should add to earnings. Neutral rating.
numbers lowered at Jefferies. Shares of ATU now seen reaching $30, Jefferies said. Estimates also lowered on slower growth in Europe. Buy rating.
Bed Bath & Beyond
(BBBY - Get Report)
numbers raised at Jefferies. Shares of BBBY now seen reaching $72, Jefferies said. Estimates also raised on strong November performance. Buy rating.